Citations (8)
Keep up to date with the latest research on this topic with citation updates for this article.
Human Vaccines & Immunotherapeutics
Volume 15, 2019 - Issue 12
Product Review
GRAZAX®: a sublingual immunotherapy vaccine for Hay fever treatment: from concept to commercialization
Domingo Barbera School of Medicine, Institute for Applied Molecular Medicine (IMMA), Universidad CEU San Pablo, Madrid, SpainCorrespondence[email protected]
https://orcid.org/0000-0002-5488-5700View further author information
https://orcid.org/0000-0002-5488-5700View further author information, , , Montserrat Fernandez-Rivasc Allergy Department, Hospital Clínico San Carlos, IdISSc, Madrid, Spainhttps://orcid.org/0000-0003-1748-2328View further author information
https://orcid.org/0000-0003-1748-2328View further author information, & Maria M. Escribesea School of Medicine, Institute for Applied Molecular Medicine (IMMA), Universidad CEU San Pablo, Madrid, Spain;e School of Medicine, Department of Basic Medical Sciences, Universidad CEU San Pablo, Madrid, Spainhttps://orcid.org/0000-0001-5057-5150View further author information
https://orcid.org/0000-0001-5057-5150View further author information